InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Tomsicek Michael John. Officer active across 2 companies, notably CRISPR Therapeutics AG. Aggregated, 2 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €82k. Activity tracked since 6 August 2021. The latest transaction was filed on 19 October 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Tomsicek Michael John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,000 shares@ US$5.32100.0% of flowCommon SharesSEC:0001209191-22-054325:0
Canonical exit: 17 Jan 2023 (T+90)
25,000 shares@ US$17.75100.0% of flowCommon SharesSEC:0001209191-21-050719:0
2 of 2 declarations
